XORTX Therapeutics Inc. Common Stock

XRTXNASDAQ • USD
0.98 USD
↘ 0.08 (7.17%)🟢PRE MARKET (AS OF 07:47 AM EST)
🟢Market: OPEN

XORTX Therapeutics Inc. Common Stock (XRTX) trades at $0.98 per share. Technical indicators currently signal "Sell". Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 18, 2026.

Open?$1.04
High?$1.04
Low?$0.98
Prev. Close?$1.06
Volume?317
Avg. Volume?N/A
VWAP?$0.98
Bid / Ask
Bid?$0.84 × 100
Ask?$1.28 × 100
Spread?$0.44
Midpoint?$1.06
Valuation & Ratios
Market Cap?2.4M
Shares Out?1.8M
Float?1.7M
Float %?96.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
Employees
3
Market Cap
2.4M
Industry
N/A
Listed
2018-05-04
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestElevated
Short % of Float?7.00%Elevated
Short Interest?122.5K
Days to Cover?2.1
Free Float1.7M
Avg Daily Volume58.4K
Settlement Date2026-10-30